Wells Fargo’s Crescent Biopharma CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4
Closed -$1.15K 7116
2024
Q1
$1.15K Hold
4
﹤0.01% 6119
2023
Q4
$890 Hold
4
﹤0.01% 6257
2023
Q3
$536 Hold
4
﹤0.01% 6350
2023
Q2
$653 Buy
4
+1
+33% +$168 ﹤0.01% 6430
2023
Q1
$370 Hold
3
﹤0.01% 6621
2022
Q4
$876 Hold
3
﹤0.01% 6230
2022
Q3
$0 Hold
3
﹤0.01% 6926
2022
Q2
$0 Hold
3
﹤0.01% 7075
2022
Q1
$0 Hold
3
﹤0.01% 7350
2021
Q4
$0 Hold
3
﹤0.01% 7450
2021
Q3
$1K Hold
3
﹤0.01% 6708
2021
Q2
$1K Sell
3
-1,102
-100% -$280K ﹤0.01% 6665
2021
Q1
$333K Buy
1,105
+47
+4% +$16.8K ﹤0.01% 4909
2020
Q4
$398K Buy
1,058
+551
+109% +$193K ﹤0.01% 4686
2020
Q3
$155K Sell
507
-1,543
-75% -$590K ﹤0.01% 5089
2020
Q2
$771K Buy
2,050
+1,160
+130% +$328K ﹤0.01% 4018
2020
Q1
$203K Buy
890
+709
+392% +$271K ﹤0.01% 4679
2019
Q4
$96K Buy
181
+1
+0.6% +$541 ﹤0.01% 5315
2019
Q3
$78K Buy
180
+10
+6% +$6.43K ﹤0.01% 5418
2019
Q2
$203K Sell
170
-34
-17% -$40.7K ﹤0.01% 4964
2019
Q1
$254K Sell
204
-45
-18% -$51.5K ﹤0.01% 4698
2018
Q4
$236K Buy
249
+81
+48% +$97.5K ﹤0.01% 4817
2018
Q3
$242K Buy
168
+11
+7% +$16.6K ﹤0.01% 4899
2018
Q2
$254K Buy
157
+156
+15,600% +$268K ﹤0.01% 4897
2018
Q1
$2K Hold
1
﹤0.01% 6194
2017
Q4
$2K Buy
+1
New +$1.32K ﹤0.01% 6188
2017
Q2
Sell
-68
Closed -$37K 6322
2017
Q1
$37K Buy
68
+27
+66% +$16.6K ﹤0.01% 5541
2016
Q4
$25K Hold
41
﹤0.01% 5571
2016
Q3
$29K Buy
+41
New +$31.4K ﹤0.01% 5497
2016
Q1
Sell
-250
Closed -$143K 6293
2015
Q4
$143K Buy
+250
New +$166K ﹤0.01% 4675

Other funds holding CBIO